Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for November 2002
November 1, 2002
- KUDCo first on market with FDA-approved Prilosec equivalent
- FDA approves marketing of Testim testosterone replacement gel
- Lexicon discovers drug development target for heart attack and stroke prevention
- Gliadel sNDA amendment includes new data on surgery death risk reduction
- Once-daily atomoxetine reduced ADHD symptoms into the evening
- Study: Early Glucobay treatment can drastically lower diabetes, cardiovascular disease risks
- Aventis Pasteur announces shipment of 43 million doses of Fluzone
November 2, 2002
November 26, 2002
- Non-stimulant Strattera is first new drug in 30 years for ADHD symptoms treatment
- Teriparatide approved for osteoporosis treatment in fracture-prone women and men
- MGI Pharma & Helsinn announce filing of NDA for palonosetron
November 27, 2002
- FDA approves OTC Claritin for seasonal allergic rhinitis
- ACAAI expresses reservations on over-the-counter loratadine
- Forest submits sNDA to market Lexapro for treatment of generalized anxiety disorder
- Daschle and Pelosi vow to repeal Homeland Security Provision shielding drug makers from liability
- Aventis discloses details of most extensive research program on Allegra
